• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
XU Tao, WANG Xiaowei, LIU Xiaorong, WANG Yazhou, LI Zhiyu. Design, synthesis and biological evaluation of ALK5 inhibitors[J]. Journal of China Pharmaceutical University, 2020, 51(4): 441-448. DOI: 10.11665/j.issn.1000-5048.20200408
Citation: XU Tao, WANG Xiaowei, LIU Xiaorong, WANG Yazhou, LI Zhiyu. Design, synthesis and biological evaluation of ALK5 inhibitors[J]. Journal of China Pharmaceutical University, 2020, 51(4): 441-448. DOI: 10.11665/j.issn.1000-5048.20200408
shu

Design, synthesis and biological evaluation of ALK5 inhibitors

  • 1.

    School of Pharmacy, China Pharmaceutical University, Nanjing 210009

  • 2.

    Nanjing Sanhome Pharmaceutical Co. , Ltd. , Nanjing 211100，China

Funds: This study was supported by the National Science and Technology Major Project for Drug Innovation (No.2018ZX09301014-006; No.2019ZX09201001-003-005)
More Information
  • Received Date: April 16, 2020
    Graphical Abstract
    • Abstract
  • Using ALK5 inhibitor LY-3200882 as a lead compound, ten structurally novel compounds were designed by bioisosterism, conformational restriction and molecular docking technology. All structures were synthesized and confirmed by 1H NMR and HR-MS. The results of in vitro activity screening showed that most compounds had good kinase inhibitory activity. Among them, compound B4 showed significantly better ALK5 inhibitory activity than LY-3200882 (IC50 = 1.4 nmol/L vs 41.1 nmol/L), and had good inhibitory activity against TGFβ-ALK5-SMAD2/3 signaling pathway in NIH3T3 cells (IC50 = 14.2 nmol/L). Besides, compound B4 had good pharmacokinetic properties, such as oral exposure and bioavailability, which is worthy of further development.
    • FullText(HTML)
    • References (9)
  • [1]
    Morikawa M，Derynck R, Miyazono K. TGF-β and the TGF-β family: context-dependent roles in cell and tissue physiology[J]. Cold Spring Harb Perspect Biol, 2016, 8(5):a021873.
    [2]
    Horbelt D, Denkis A, Knaus P. A portrait of transforming growth factor β superfamily signalling: background matters[J]. Int J Biochem Cell Biol, 2012, 44(3):469-474.
    [3]
    Xiaoling T, Wencai G, Lingyun Z, et al. Physical interaction of STAT1 isoforms with TGF-β receptors leads to functional crosstalk between two signaling pathways in epithelial ovarian cancer[J]. J Exp Clin Canc Res, 2018, 37(1):103.
    [4]
    Heldin CH, Moustakas A. Signaling receptors for TGF-β family members[J]. Cold Spring Harb Perspect Biol, 2016, 8(8):a022053.
    [5]
    Padua D, MassaguéJoan. Roles of TGFβ in metastasis[J]. Cell Res, 2016, 19(1):89-102.
    [6]
    Pickup M, Novitskiy S, Moses HL. The roles of TGFβ in the tumour microenvironment[J]. Nat Rev Cancer, 2013, 13(11):788-799.
    [7]
    Batlle E, Massague J. Transforming growth factor-beta signaling in immunity and cancer[J]. Immunity, 2019, 50(4):924-940.
    [8]
    Pei H, Parthasarathy S, Joseph S, et al. LY3200882, a novel, highly selective TGFβRI small molecule inhibitor[J]. Cancer Res, 2017, 77:955.
    [9]
    Goldberg FW , Ward RA , Powell SJ , et al. Rapid generation of a high quality lead for transforming growth factor-β (TGF-β) type I receptor (ALK5)[J]. J Med Chem, 2009, 52(23):7901-7905.
    • Related Articles

  • Related Articles

    [1]HOU Kai, LI Ping, ZHANG Jinlian, WANG Fang, YANG Yu. Blood coagulation factor XI: new strategy of targeted anticoagulant therapy[J]. Journal of China Pharmaceutical University, 2024, 55(5): 708-714. DOI: 10.11665/j.issn.1000-5048.2023050101
    [2]YE Zhenning, WU Zhenghong, ZHANG Huaqing. Research progress of blood-brain barrier crossing strategies and brain-targeted drug delivery mediated by nano-delivery system[J]. Journal of China Pharmaceutical University, 2024, 55(5): 590-602. DOI: 10.11665/j.issn.1000-5048.2024052202
    [3]LIU Yanhong, CHEN Liqing, ZHANG Xintong, GAO Zhonghao, HUANG Wei. Research progress of tumor immunomodulation strategies based on nanodrug delivery system[J]. Journal of China Pharmaceutical University, 2023, 54(1): 5-14. DOI: 10.11665/j.issn.1000-5048.2023021501
    [4]WANG Yanmei, YANG Lei, XIN Xiaofei, YIN Lifang. Combination therapy and drug delivery strategies for treatment of non-alcoholic fatty liver disease[J]. Journal of China Pharmaceutical University, 2022, 53(4): 423-432. DOI: 10.11665/j.issn.1000-5048.20220405
    [5]ZHOU Xinyuan, LIU Nan, ZHANG Pan, HUO Meirong. Advances in research on therapeutic strategies of targeting pancreatic cancer stroma[J]. Journal of China Pharmaceutical University, 2021, 52(6): 653-662. DOI: 10.11665/j.issn.1000-5048.20210602
    [6]FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406
    [7]YANG Shan, XU Cheng, YAO Jing. Strategies of nano drug delivery system applied in anti-angiogenic therapy[J]. Journal of China Pharmaceutical University, 2019, 50(1): 11-18. DOI: 10.11665/j.issn.1000-5048.20190102
    [8]SONG Ke, PAN Hao, HAN Jiayi, CHEN Lijiang. Nano drug delivery system based strategies to target tumor microenvironment[J]. Journal of China Pharmaceutical University, 2018, 49(4): 392-400. DOI: 10.11665/j.issn.1000-5048.20180402
    [9]SU Zhigui, MO Ran, ZHANG Can. Advances of nano-drug delivery systems overcoming the physiological and pathological barriers of tumor[J]. Journal of China Pharmaceutical University, 2015, 46(1): 28-39. DOI: 10.11665/j.issn.1000-5048.20150103
    [10]KE Xue. Advances in targeted drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(1): 9-15.

  • Cited by

    Periodical cited type(2)

    1. 翟允耀，章晓骅. 化学仿制药制剂开发中晶型研究思路探讨. 药品评价. 2024(02): 131-133 .
    2. 梁霖霖，王志伟，何小双，衡伟利，钱帅，高缘，张建军，魏元锋. 机械外力对中药提取物晶体学固态形式及溶出速率的影响研究——以女贞子提取物为例. 中国药科大学学报. 2024(06): 767-774 . 本站查看

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views PDF downloads Cited by(2)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：365829

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return